New treatment options for substance abuse from a public health viewpoint

Annals of Medicine

Volumn 30, Issue 4, 1998, Pages 406-411

  Sinclair, John David ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Alcoholism; Extinction; Methadone; Naltrexone; Opiates; Public health

Indexed keywords

DISULFIRAM; METHADONE; NALTREXONE; OPIATE ANTAGONIST;

ALCOHOL ABUSE; ALCOHOLISM; CLINICAL PROTOCOL; DRINKING BEHAVIOR; HUMAN; METHADONE TREATMENT; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SUBSTANCE ABUSE;

EID: 0031718295     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809029941     Document Type: Review

References (29)

1. Sinclair JD. The feasibility of effective psychopharmacological treatments for alcoholism. Br J Addiction 1987; 82: 1213-23.
2. Volpicelli JR, O'Brien CP, Alterman AI, Hayashida M. Naltrexone and the treatment of alcohol dependence: initial observations. In: Reid LD, ed. Opioids, Bulimia, and Alcohol Abuse & Alcoholism. New York: Springer Verlag; 1990: 195-214.
3. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 876-80.
4. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 1992; 49: 881-7.
5. Litten RZ, Fertig J, Croop RS, et al. International update: new findings on promising medications. Alcohol Clin Exp Res 1996; 20: 216A-8A.
6. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP. Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry 1997; 54: 737-42.
7. Balldin J, Berglund M, Borg S, et al. A randomized 6 month double-blind placebo-controlled study of naltrexone and coping skills education programme. Alcohol Alcohol 1997; 32: 325.
8. Mason BJ, Ritvo EC, Morgan RO, et al. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCL for alcohol dependence. Alcohol Clin Exp Res 1994; 18: 1162-7.
9. Mason, B. Dosing issues in the pharmacotherapy of alcoholism. Alcohol Clin Exp Res 1996: 20: 10A-6A.
10. Bohn MJ, Kranzler HR, Beazoglou D, Staehler BA. Naltrexone and brief counseling to reduce heavy drinking. Am J Addict 1994; 3: 91-9.
11. Kranzler HR, Tennen H, Penta C, Bohn MJ. Targeted naltrexone treatment of early problem drinkers. Addict Behav 1997; 22: 431-6.
12. Maxwell S, Shinderman MS. Naltrexone in the treatment of dually-diagnosed patients (abstract). J Addict Dis 1997; 16: 125.
13. Sinclair D. Development in Finland of the extinction treatment for alcoholism with naltrexone. Psychiatria Fennica 1997; 28: 76-97.
14. Croop RS, Faulkner EB, Labriola DF. The safety profile of naltrexone in the treatment of alcoholism: results from a multicenter usage study. The Naltrexone Usage Study Group. Arch Gen Psychiatry 1997; 54: 1130-5.
15. Agosti V. The efficacy of controlled trials of alcohol misuse treatments in maintaining abstinence. Int J Addict 1994; 29: 759-69.
16. Agosti V. The efficacy of treatment in reducing alcohol consumption: a meta-analysis. Int J Addict 1995; 30: 1067-77.
17. O'Malley SS, Jaffe AJ, Chang G, et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996; 53: 217-24.
18. Sinclair JD. Drugs to decrease alcohol drinking. Ann Med 1990; 22: 357-62.
19. Sinclair JD. The story in Finland behind the new naltrexone treatment for alcoholism (and how I got the patent for it). Life and Education in Finland 1995; (3): 2-16.
20. Sinclair JD. Laboratory animal research in the discovery and development of the new alcoholism treatment using opioid antagonists. Scand J Lab Animal 1996; 23 (Suppl 1): 379-90.
21. Myers RD, Lankford MF. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone. Neuropsychopharmacology 1996; 14: 139-49.
22. Sinclair JD. From optimal complexity to the naltrexone extinction of alcoholism. In: Hoffman R, Sherrick MF, Warm JS, eds. Viewing Psychology as a Whole: The Integrative Science of William N. Dember. Washington, DC: American Psychological Association; 1998: 491-508.
23. Altshuler HL, Phillips PE, Feinhandler DA. Alteration of ethanol self-administration by naltrexone. Life Sci 1980; 26: 679-88.
24. Hyytiä P, Sinclair JD. Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol Clin Exp Res 1993; 17: 631-6.
25. Renault PF. Treatment of heroin-dependent persons with antagonists: current status. In: Willett RE, Barnett G, eds. Naltrexone: Research Monograph 28. Washington, DC: National Institute on Drug Abuse; 1980: 11-22.
26. Moncrieff J, Drummond DC. New drug treatments for alcohol problems: a critical appraisal. Addiction 1997; 92: 939-47.
27. Davis WM, Smith SG. Naloxone use to eliminate opiate-seeking behavior: need for extinction of conditioned reinforcement. Biol Psychiatry 1974; 9: 181-39.
28. Sinclair JD, Jääskeläinen IP. Continued efficacy after naloxone-induced suppression of alcohol drinking: dependence upon relative timing. Alcohol Clin Exp Res 1995: 19 (Suppl): 13A.
29. Marck MC, Liepa GU, Kalia SJ, Daoud MC. Investigating differences in hospitalized patients detoxified with lorazepam vs. phenobarbital relative to length of stay, average total cost, and use of restraints. J Addict Dis 1997; 16: A23.